Opus Biological is committed to providing only ethical and research-driven therapy for the treatment of musculoskeletal disease.
Osteoarthritis is the most prevalent chronic joint disease. It frequently causes joint pain, loss of function and even disability. Globally an estimated 10-15% of people suffer from osteoarthritis. Research has shown us how the disease leads to the destruction of joints with pain and stiffness suffered by those affected. Orthobiological treatments like PRP and Mesenchymal Stem Cells are changing how we treat this condition by regenerating diseased tissue.